| Literature DB >> 26378620 |
Roland D Kersten1, Jolene K Diedrich2,3, John R Yates2,3, Joseph P Noel1.
Abstract
Terpenes are ubiquitous natural chemicals with diverse biological functions spanning all three domains of life. In specialized metabolism, the active sites of terpene synthases (TPSs) evolve in shape and reactivity to direct the biosynthesis of a myriad of chemotypes for organismal fitness. As most terpene biosynthesis mechanistically involves highly reactive carbocationic intermediates, the protein surfaces catalyzing these cascade reactions possess reactive regions possibly prone to premature carbocation capture and potentially enzyme inactivation. Here, we show using proteomic and X-ray crystallographic analyses that cationic intermediates undergo capture by conserved active site residues leading to inhibitory self-alkylation. Moreover, the level of cation-mediated inactivation increases with mutation of the active site, upon changes in the size and structure of isoprenoid diphosphate substrates, and alongside increases in reaction temperatures. TPSs that individually synthesize multiple products are less prone to self-alkylation then TPSs possessing relatively high product specificity. In total, the results presented suggest that mechanism-based alkylation represents an overlooked mechanistic pressure during the evolution of cation-derived terpene biosynthesis.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26378620 PMCID: PMC4655415 DOI: 10.1021/acschembio.5b00539
Source DB: PubMed Journal: ACS Chem Biol ISSN: 1554-8929 Impact factor: 5.100
Figure 1Structural basis of cyclic sesquiterpene biosynthesis and carbocation quenching scenarios in sesquiterpene synthases. (a) Active site model of wild-type TEAS with bound substrate mimic 1-hydroxyfarnesyl phosphonate (colored yellow) based on Protein Data Bank entry 5EAT.[19] Selected active site residues are displayed and numbered. The dynamic active site J/K loop is colored magenta. Three Mg2+ ions are highlighted as gray spheres and waters as red crosses. Active site mutation sites for alkylation studies (Table ) are colored orange. (b) Carbocation quenching scenarios in sesquiterpene synthases. During enzyme-catalyzed sesquiterpene cyclization, cationic intermediates are neutralized by deprotonation as exemplified by the proposed last step in 5-epi-aristolochene biosynthesis,[19] quenching with an exogenous nucleophile such as water exemplified by the proposed last step in patchoulol biosynthesis,[9] or quenching with an endogenous nucleophile such as an active site residue to yield an alkylated active site. Biosynthetic steps in TPS active sites are highlighted in gray.
Alkylation Analyses of Specific (dominant-product) and Promiscuous (multiproduct) Sesquiterpene Synthasesa
| terpene synthase (organism) | product specificity (wt) | mutation | temp (°C) | substrate | alkylation on the “NSE/DTE” motif [peptide with a putative alkyation sites (*)] | alkylation on the active site lid [peptide with a putative alkylation site (*)] | main product |
|---|---|---|---|---|---|---|---|
| 5- | dominant-product | wt | 25 | ( | N/D | N/D | 5- |
| W273C | 25 | ( | yes (V442ID*DTATYEVEK453) | yes (I515VEVTY*IHNLDGYTHPEK532) | β-farnesene | ||
| W273E | 25 | ( | yes (V442ID*DTATYEVEK453) | yes (I515VEVTY*IHNLDGYTHPEK532) | β-farnesene | ||
| W273F | 25 | ( | yes (V442ID*DTATYEVEK453) | yes (I515VEVTY*IHNLDGYTHPEK532) | β-farnesene | ||
| V277L | 25 | ( | yes (V442ID*DTATYEVEK453) | N/D | 5- | ||
| Y404C | 25 | ( | yes (V442ID*DTATYEVEK453) | yes (I515VEVTY*IHNLDGYTHPEK532) | unknown | ||
| Y404F | 25 | ( | yes (V442ID*DTATYEVEK453) | yes (I515VEVTY*IHNLDGYTHPEK532) | 5- | ||
| L407I | 25 | ( | yes (V442ID*DTATYEVEK453) | yes (I515VEVTY*IHNLDGYTHPEK532) | 5- | ||
| L407P | 25 | ( | yes (V442ID*DTATYEVEK453) | N/D | 5- | ||
| L512I | 25 | ( | yes (V442ID*DTATYEVEK453) | N/D | 5- | ||
| wt | 37 | ( | N/D | N/D | 5- | ||
| wt | 42 | ( | yes (V442ID*DTATYEVEK453) | N/D | 5- | ||
| wt | 25 | ( | N/D | yes (I515VEVTY*IHNLDGYTHPEK532) | 5- | ||
| wt | 25 | SPP | yes (V442ID*DTATYEVEK453) | yes (I515VEVTY*IHNLDGYTHPEK532) | sesquilavandulene | ||
| premnaspirodiene
synthase
( | dominant-product | wt | 25 | ( | N/D | N/D | premnaspirodiene |
| W280E | 25 | ( | yes (V449VD*DIATYEVEK460) | yes (I522IDVTY*K528) | premnaspirodiene | ||
| wt | 25 | SPP | yes (V449VD*DIATYEVEK460) | yes (I522IDVTY*K528) | sesquilavandulene | ||
| wt | 25 | ( | yes (V449VD*DIATYEVEK460) | yes (I522IDVTY*K528) | unknown | ||
| valencene synthase
( | dominant-product | wt | 25 | ( | N/D | N/D | valencene |
| W273E | 25 | ( | N/D | yes (A517IDFIY*KEDDGYTHSYLIK535) | unknown | ||
| wt | 25 | SPP | N/D | N/D | unknown | ||
| aristolochene synthase ( | dominant-product | wt | 25 | ( | N/D | N/D | aristolochene |
| Y61C | 25 | ( | yes (H214LSVVN*DIYSYEK226) | N/D | unknown | ||
| patchoulol synthase ( | multiproduct | wt | 25 | ( | N/D | N/D | patchoulol |
| W276E | 25 | ( | N/D | N/D | unknown | ||
| wt | 25 | SPP | yes (L447VN*DITGHEFEK458) | N/D | sesquilavandulene | ||
| santalene synthase
( | multiproduct | wt | 25 | ( | N/D | N/D | α-santalene |
| W293E | 25 | ( | N/D | N/D | β-bergamotene | ||
| wt | 25 | SPP | N/D | N/D | unknown | ||
| γ-humulene synthase
( | multiproduct | wt | 25 | ( | N/D | N/D | γ-humulene |
| W315P | 25 | ( | N/D | N/D | β-farnesene | ||
| wt | 25 | SPP | N/D | N/D | unknown |
For detailed MS and MS/MS analyses, see Figures S2, S3, S8, S12, and S14. For GC–MS analyses, see Figures S4, S9, and S13. Product specificities describe wild-type enzyme specificities. Abbreviations: N/D, not detected; wt, wild type.
Figure 2Self-alkylation analysis of TEAS active site mutant W273E with (E,E)-farnesyl diphosphate. (A) LC–MS analysis of a tryptic digest of TEAS W273E after reaction with (E,E)-farnesyl diphosphate. Two tryptic peptides encompassing active site residues, V[442–453]K and I[515–532]K, showed an alkylation mass shift (red chromatograms). (B) MS analysis of alkylated and nonalkylated tryptic peptides V[442–453]K and I[515–532]K. For detailed MS/MS analysis, see Figure S2. (C) X-ray crystallographic analysis of alkylated TEAS W273E reveals a C1-farnesyl-γO-aspartate ester at Asp444. (D) X-ray crystallographic analysis of nonalkylated TEAS W273E. The electron density from unbiased (i.e., simulated-annealing omit) sigma-A-weighted 2Fo – Fc maps is shown at contour level 0.8σ with refined active site models in panels C and D. (E) Characterization of alkylation site Asp444 by EThcD-MS/MS analysis of alkylated tryptic peptide V[442–453]K. See also Figure S5. Abbreviations: BPC, base peak chromatogram; m(obs), observed mass; m(calc), calculated mass; ESI, electrospray ionization; Δm, mass error; EThcD, electron transfer and high-energy collision dissociation; FTMS, Fourier transform ion cyclotron resonance mass spectrometry.
GC–MS Analyses of Product Yields of TEAS Reactions with (E,E)-FPP Depending on the Alkylation Statea
| reaction time | |||
|---|---|---|---|
| protein | 0–12 h | 12–24 h | product yield
(%) |
| TEAS W273E | no FPP | FPP | 100 (β-farnesene) |
| FPP | FPP | 1 ± 0.3 (β-farnesene) | |
| FPP | no FPP | N/D | |
| TEAS Y404F | no FPP | FPP | 100 (5EA) |
| FPP | FPP | 86 ± 7 (5EA) | |
| FPP | no FPP | N/D | |
| TEAS wild type | no FPP | FPP | 100 (5EA) |
| FPP | FPP | 105 ± 11 (5EA) | |
| FPP | no FPP | N/D | |
Analyzed TEAS constructs were TEAS W273E, TEAS Y404F, and wild-type TEAS. Abbreviations: SD, standard deviation; 5EA, 5-epi-aristolochene; N/D, not detected.
Means ± the standard deviation, reactions in triplicate (2.5 μM enzyme and 250 μM FPP).
Figure 3Self-alkylation analysis of wild-type TEAS with (E,E)-farnesyl diphosphate analogues at different reaction temperatures. (A) Sesquiterpene substrates tested in self-alkylation studies (Table ). (B) Self-alkylation analysis of wild-type TEAS with sesquilavandulyl diphosphate (SPP). (C) Self-alkylation analysis of wild-type TEAS with (E,E)-FPP at 25 and 42 °C. For detailed MS and MS/MS analysis, see Figure S8.